Stock Analysis·← Pickers

MLEC

Moolec Science S.A.

Moolec Science S.A. (MLEC) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 41.8, with 0/3 trend checks passing.

Price
$7.12
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
41.8
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

MLEC with MA50 and MA200

92.9170.5248.1425.753.3707/3110/2401/2204/1707/15
MLEC2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$7.84-9.24% vs price
MA200
$8.23-13.45% vs price
RSI (14)
41.8Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for MLEC

Moolec Science S.A. (MLEC) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $7.12, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 9.2% and below the 200-day moving average by 13.4%.

Momentum and stretch context

MLEC currently has an RSI reading of 41.8, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing MLEC next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Moolec Science S.A.

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company is based in Grand Cayman, Cayman Islands.

Sector
Healthcare
Industry
Biotechnology
CEO
Alejandro Antalich
Employees
103
Market cap
$5.2M
Beta
0.26
52-week range
$3.08 – $65.85
Dividend
No
Exchange
NASDAQ
Country
KY
IPO date
2 Mar 2021
ISIN
KYG6223S1259
CUSIP
G6223S125
Company profile data from Financial Modeling Prep. MLEC listed on NASDAQ.
Share dilution

MLEC shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Dec 2020Dec 2024
Shares outstanding (latest)
2.6M
Since Dec 2020
+124.3%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. MLEC17 data points from Dec 2020 to Dec 2024.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about MLEC

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

MLEC Stock Analysis: Downtrend, below MA50 & MA200, RSI 42 | MyStockHarbor